Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual MeetingGlobeNewsWire • 05/06/21
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021GlobeNewsWire • 04/12/21
Organogenesis Holdings' (ORGO) Shares March Higher, Can It Continue?Zacks Investment Research • 03/26/21
Avista Healthcare Earns Membership In 95-Plus Composite Rating ClubInvestors Business Daily • 03/19/21
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/17/21
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 GuidanceGlobeNewsWire • 03/16/21
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and MarchGlobeNewsWire • 02/09/21
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021GlobeNewsWire • 02/08/21
Earnings Estimates Rising for ORGANOGENESIS (ORGO): Will It Gain?Zacks Investment Research • 01/20/21
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee OsteoarthritisGlobeNewsWire • 01/14/21
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020GlobeNewsWire • 01/13/21
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the KneeGlobeNewsWire • 01/11/21